CardioVascular BioTherapeutics (fka CVBT)

[Beachbum3232]

I'll tell you who would invest in this company, those who value the IP, the patents, the platform. If Wallen's team doesn't pull this off, the value of these patents are worth quite a bit I'm sure. I'm not an expert on this but I would think if CVBT found itself in a no win situation, they could at least sell their assets or be acquired. I don't see that helping us unfortunately ( unless we are relisted when this happens) but I'm simply replying to Wallhall's question about who would invest in this company.

On the flip-side, if we get this sucker up and running, the assets will be worth more as they enter later stages of development and hopefully by that time CVBT is relisted.

It's all speculation but these are the two scenarios that I'm focused on.